1. Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19

   • Chia Siang Kow
   • Syed Tabish Razi Zaidi
   • Syed Shahzad Hasan

   Current Opinion 13 April 2020 Pages: 217 - 221

2. Tinzaparin Sodium Pharmacokinetics in Patients with Chronic Kidney Disease: Practical Implications

   • Hélène Helfer
   • Virginie Siguret
   • Isabelle Mahé

   Current Opinion Open access 13 November 2019 Pages: 223 - 228

   

3. Non-inferiority Trial Design in Drug Development: A Primer for Cardiovascular Healthcare Professionals

   • Fabio Angeli
   • Paolo Verdecchia
   • Gianpaolo Reboldi

   Review Article 24 October 2019 Pages: 229 - 238

   

4. Lipid-Lowering Efficacy of Ezetimibe in Patients with Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analyses

   • Fadia Tohme Shaya
   • Krystal Sing
   • Miraj Y. Patel

   Systematic Review Open access 14 November 2019 Pages: 239 - 248

   

5. Bioequivalence of a Newly Developed Dabigatran Etexilate Tablet Versus the Commercial Capsule and Impact of Rabeprazole-Induced Elevated Gastric pH on Exposure in Healthy Subjects

   • Akiko Harada
   • Ippei Ikushima
   • Daisuke Nakayama

   Original Research Article Open access 30 October 2019 Pages: 249 - 258

   

6. Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries

   • Mattia Peyracchia
   • Andrea Saglietto
   • Fabrizio D’Ascenzo

   Original Research Article 05 October 2019 Pages: 259 - 269

7. Dexmedetomidine Reduces Atrial Fibrillation After Adult Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials

   • Yang Liu
   • Lei Zhang
   • Wei Chen

   Original Research Article 14 November 2019 Pages: 271 - 281

   

8. Effects of Metformin on Left Ventricular Size and Function in Hypertensive Patients with Type 2 Diabetes Mellitus: Results of a Randomized, Controlled, Multicenter, Phase IV Trial

   • Koh Ono
   • Hiromichi Wada
   • the ABLE-MET Investigators

   Original Research Article Open access 13 November 2019 Pages: 283 - 293

   

9. Reversal of Apixaban and Rivaroxaban Using Activated Prothrombin Complex Concentrates in Patients with Major Bleeding

   • Marwan Sheikh-Taha
   • R. Monroe Crawley

   Original Research Article 11 November 2019 Pages: 295 - 299